Female infertility, infertility-associated diagnoses, and comorbidities: a review
- 1.9k Downloads
The purpose of the study is to evaluate existing literature for possible associations between female infertility, infertility-associated diagnoses, and the following areas of disease: psychiatric disorders, breast cancer, ovarian cancer, endometrial cancer, cardiovascular disease, and metabolic dysfunction.
The design of the study is a literature review. The patients were women included in 26 selected studies due to a diagnosis of infertility or a reproductive disorder associated with infertility. This study has no interventions, and the main outcome measure is the association between female infertility or a related diagnosis and psychiatric disorders, breast cancer, ovarian cancer, endometrial cancer, cardiovascular disease, and metabolic dysfunction.
Female infertility and related reproductive disorders may have ramifications for women beyond reproductive health. An analysis of publications shows that women with infertility had higher rates of psychiatric disorders and endometrial cancer than the general population [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]. Data is conflicting about whether infertile women are at increased risk for breast cancer and ovarian cancer [7, 8, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20]. A generalized diagnosis of infertility was not clearly associated with an increased risk of cardiovascular disease or metabolic dysfunction, but women with infertility related to polycystic ovarian syndrome (PCOS) do appear more likely to develop cardiovascular disease and metabolic disorders such as diabetes than the general population [16, 21, 22, 23, 24, 25, 26].
Female infertility and associated diagnoses have overall health implications. Beyond treatment of patients’ immediate reproductive needs, healthcare professionals must be aware of the broader health impact of specific causes of infertility in order to provide accurate counseling regarding long-term risk.
KeywordsInfertility In vitro fertilization Malignancy Somatic health Fertility drugs
- 1.Valoriani VFL, Lari D, Miccinesi G, Vaiani S, Vanni C, Coccia ME, et al. Differences in psychophysical well-being and signs of depression in couples undergoing their first consultation for assisted reproduction technology (ART): an Italian pilot study. Europ J Obstet Gynecol Reprod Biol. 2016;197:179–85.CrossRefGoogle Scholar
- 3.Gokhan A. Level of anxiety, depression, self esteem, social anxiety, and quality of life among women with polycystic ovarian syndrome. Sci World J. 2013;2013:7.Google Scholar
- 18.Cirillo P. Irregular menses predicts ovarian cancer. Int J Cancer. 2016.Google Scholar
- 20.Rizzuto I. Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility. Cochrane Database Syst Rev. 2013:8.Google Scholar
- 21.Parikh N. Reproductive risk factors and coronary heart disease in the Women’s Health Initiative Observational Study. Circulation. 2016.Google Scholar
- 23.El-Hayek. Polycystic ovarian syndrome: an updated overview. Front Physiol. 2016. 7(124).Google Scholar
- 26.Ramezani-Binabaj M. Are women with polycystic ovarian syndrome at high risk of non-alcoholic fatty liver disease; a meta-analysis. Hepat Mon. 2014. 14(11): p.Google Scholar
- 27.Aghajanova L. Obstetrics and gynecology residency and fertility needs: national survey results. Reprod Sci. 2016.Google Scholar
- 28.Prevention C.f.D.C.a. Assisted reproductive technology success rates: national summary and fertility clinic reports. US Department of Health and Human Services. 2010.Google Scholar
- 29.SART, National Summary Report. 2014, Society for Assisted Reproductive Technology: SART Website (www.sart.org).
- 31.Tarin J. Infertility etiologies are genetically and clinically linked with other diseases in single meta-diseases. Reprod Biol Endocrinol. 2015. 13(31).Google Scholar